Talaris Therapeutics Price Prediction
| TALSDelisted Stock | USD 2.98 0.10 3.25% |
Oversold Vs Overbought
56
Oversold | Overbought |
Using Talaris Therapeutics hype-based prediction, you can estimate the value of Talaris Therapeutics from the perspective of Talaris Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Talaris Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Talaris because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Talaris Therapeutics after-hype prediction price | USD 2.98 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Talaris |
Talaris Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Talaris Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Talaris Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Talaris Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Talaris Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Talaris Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Talaris Therapeutics' historical news coverage. Talaris Therapeutics' after-hype downside and upside margins for the prediction period are 2.98 and 2.98, respectively. We have considered Talaris Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Talaris Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Talaris Therapeutics is based on 3 months time horizon.
Talaris Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Talaris Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Talaris Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Talaris Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 9 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.98 | 2.98 | 0.00 |
|
Talaris Therapeutics Hype Timeline
Talaris Therapeutics is at this time traded for 2.98. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Talaris is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Talaris Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 2.98. About 78.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.28. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Talaris Therapeutics recorded a loss per share of 1.97. The entity last dividend was issued on the 19th of October 2023. Given the investment horizon of 90 days the next expected press release will be in a few days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.Talaris Therapeutics Related Hype Analysis
Having access to credible news sources related to Talaris Therapeutics' direct competition is more important than ever and may enhance your ability to predict Talaris Therapeutics' future price movements. Getting to know how Talaris Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Talaris Therapeutics may potentially react to the hype associated with one of its peers.
Talaris Therapeutics Additional Predictive Modules
Most predictive techniques to examine Talaris price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Talaris using various technical indicators. When you analyze Talaris charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Talaris Therapeutics Predictive Indicators
The successful prediction of Talaris Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Talaris Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Talaris Therapeutics based on analysis of Talaris Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Talaris Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Talaris Therapeutics's related companies.
Story Coverage note for Talaris Therapeutics
The number of cover stories for Talaris Therapeutics depends on current market conditions and Talaris Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Talaris Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Talaris Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Talaris Therapeutics Short Properties
Talaris Therapeutics' future price predictability will typically decrease when Talaris Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Talaris Therapeutics often depends not only on the future outlook of the potential Talaris Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Talaris Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.2 M | |
| Cash And Short Term Investments | 181.3 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Talaris Stock
If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |